UCLA: Clinical Trials & Research Profile
Academic / Cooperative Group (Los Angeles, CA) · Primary Focus: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Academic / Cooperative Group (Los Angeles, CA) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 71 active (46 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 118 (107 with California sites) |
| Completed vs Early-Stopped Studies | 22 completed / 24 stopped (20.3% stop rate) |
| Median Closed Enrollment | 29 participants |
| FDA Drugs@FDA Original Approvals | 0 all-time (0 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 100.0% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for UCLA Health across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk